[Administration of anti-HER2 and satisfaction of patients treated for breast cancer].

Introduction: Quality of life (QoL) and patient satisfaction are major concerns in oncology.

Methods: The aim of this prospective observational study was to evaluate these parameters according to the mode of administration of anti-HER2 (subcutaneous [SC] versus intravenous [IV]), the place of administration (Home Hospitalization or HOD versus hospital) for patients supervised by an advanced practice nurse (APN).

Results: Between January 2022 and June 2023, 32 patients were included.